How Oropouch Fever is Impacting Brazil
A midge up-close. Image credit: Florida Environmental Pest Management Oropouche fever, a disease caused by Oropouche virus has increasingly caused international concern in recent months, drawing attention to emerging infectious diseases and arboviruses. Spread by infected biting midges and occasionally mosquitoes, this disease has primarily occurred in Central and South America, as well as the […]
FDA Decisions to Watch Q1-Q2: Infectious Disease
CHIKV VLP PDUFA Date: 2/14/2025 Company: Bavarian Nordic The CHIKV VLP vaccine is a single-dose vaccine aimed at preventing chikungunya virus, which is transmitted by mosquitoes and can cause fever and debilitating joint pain. If approved, this will be the first and only VLP-based vaccine for chikungunya available in the US The vaccine is being […]
Genetic ‘fingerprint’ to predict drug resistance in bacteria
Antibiotic resistance is a global public health crisis responsible for more than a million deaths annually. By 2050, the World Health Organization estimates it could surpass cancer and heart disease as the leading cause of death as more bacteria develop defenses to the drugs designed to combat them. Now Tulane University researchers have identified a […]
State of Kansas Reports Country’s Largest Tuberculosis Outbreak
This is a medical illustration of drug-resistant, Mycobacterium tuberculosis bacteria, presented in the Centers for Disease Control and Prevention (CDC) publication entitled, Antibiotic Resistance Threats in the United States, 2019 (AR Threats Report). Illustrator credit: Alissa Eckert; James Archer The Kansas Department of Health and Environment (KDHE) is reporting a tuberculosis (TB) outbreak in the […]
Immune Deficits in Some Valley Fever Patients Hinder Response to Antifungal Treatment
Valley fever, caused by Coccidioides fungi, remains a serious concern, particularly in regions like California and Arizona. Antifungal treatments are effective for many patients, but for others, they’re not enough. George Thompson, MD, professor of infectious disease at UC Davis Medical Center, sheds light on this issue and the ongoing research efforts to better understand […]
The Urgent Case for Recommitting to Global HIV/AIDS Goals
This Viewpoint discusses the need to recommit to the fight against HIV/AIDS to reach the United Nation’s 2030 goal of ending the epidemic as a public health threat. Source link
Patient Information: Genital Herpes
This JAMA Patient Page describes genital herpes and its symptoms, diagnosis, treatment, and prevention measures. Source link
Lenacapavir for Individuals Adherent to Daily Oral PrEP
This Viewpoint discusses the potential advantages of injectable preexposure prophylaxis (PrEP) drugs such as lenacapavir for persons unable to adhere to daily oral HIV PrEP and highlights ways in which lenacapavir and expanded PrEP options could offer tailored and effective ways to better meet the diverse needs of at-risk individuals. Source link
